Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBIT Margin (2020 - 2025)

Sotera Health has reported EBIT Margin over the past 6 years, most recently at 35.73% for Q4 2025.

  • Quarterly results put EBIT Margin at 35.73% for Q4 2025, up 570.0% from a year ago — trailing twelve months through Dec 2025 was 33.75% (up 671.0% YoY), and the annual figure for FY2025 was 33.75%, up 671.0%.
  • EBIT Margin for Q4 2025 was 35.73% at Sotera Health, down from 36.7% in the prior quarter.
  • Over the last five years, EBIT Margin for SHC hit a ceiling of 36.7% in Q3 2025 and a floor of 15.13% in Q1 2023.
  • Median EBIT Margin over the past 5 years was 27.98% (2024), compared with a mean of 27.6%.
  • Biggest five-year swings in EBIT Margin: plummeted -50157bps in 2021 and later soared 962bps in 2023.
  • Sotera Health's EBIT Margin stood at 27.53% in 2021, then decreased by -13bps to 23.92% in 2022, then skyrocketed by 40bps to 33.53% in 2023, then decreased by -10bps to 30.03% in 2024, then increased by 19bps to 35.73% in 2025.
  • The last three reported values for EBIT Margin were 35.73% (Q4 2025), 36.7% (Q3 2025), and 33.2% (Q2 2025) per Business Quant data.